Immunic Statistics
Share Statistics
Immunic has 95.82M
shares outstanding. The number of shares has increased by 0%
in one year.
| Shares Outstanding | 95.82M |
| Shares Change (YoY) | 0% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 50.44% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 542 |
| FTD / Avg. Volume | 0.06% |
Short Selling Information
The latest short interest is 2.74M, so 2.86% of the outstanding
shares have been sold short.
| Short Interest | 2.74M |
| Short % of Shares Out | 2.86% |
| Short % of Float | 2.92% |
| Short Ratio (days to cover) | 1.88 |
Valuation Ratios
The PE ratio is -1 and the forward
PE ratio is -1.42.
Immunic's PEG ratio is
0.02.
| PE Ratio | -1 |
| Forward PE | -1.42 |
| PS Ratio | 0 |
| Forward PS | 0.1 |
| PB Ratio | 5.44 |
| P/FCF Ratio | -1.18 |
| PEG Ratio | 0.02 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Immunic.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.77,
with a Debt / Equity ratio of 0.05.
| Current Ratio | 1.77 |
| Quick Ratio | 1.77 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | -0.01 |
| Debt / FCF | -0.01 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | $-1,104,472.53 |
| Employee Count | 91 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -27.56% in the
last 52 weeks. The beta is 1.73, so Immunic's
price volatility has been higher than the market average.
| Beta | 1.73 |
| 52-Week Price Change | -27.56% |
| 50-Day Moving Average | 1.06 |
| 200-Day Moving Average | 1.21 |
| Relative Strength Index (RSI) | 40.96 |
| Average Volume (20 Days) | 882,460 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -98.05M |
| Net Income | -100.51M |
| EBITDA | -100.37M |
| EBIT | -100.51M |
| Earnings Per Share (EPS) | -1 |
Full Income StatementBalance Sheet
The company has 35.67M in cash and 1M in
debt, giving a net cash position of 34.66M.
| Cash & Cash Equivalents | 35.67M |
| Total Debt | 1M |
| Net Cash | 34.66M |
| Retained Earnings | -511.4M |
| Total Assets | 20.52M |
| Working Capital | -6.62M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -84.77M
and capital expenditures -264K, giving a free cash flow of -85.03M.
| Operating Cash Flow | -84.77M |
| Capital Expenditures | -264K |
| Free Cash Flow | -85.03M |
| FCF Per Share | -0.85 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
